Sven Håkan Björklund is a Swedish businessperson who has been the head of 24 different companies.
He is Chairman-Supervisory Board at QIAGEN NV, Chairman for Swedish Orphan Biovitrum AB, Chairman of Jordberga Gård AB, Chairman at Trimb Holding AB, Chairman at Kibacq AB, Chairman of Gyllebo Slott AB, Chairman of Acino International AG, Chairman for BONE SUPPORT AB and Chairman of Trimb Healthcare AB. Dr. Björklund is also on the board of BONESUPPORT HOLDING AB (former Chairman) and Partner at Tellacq AB.
He previously occupied the position of Chairman at Fougera Luxco SA, Chief Executive Officer for Nycomed AB, Chief Executive Officer for Nycomed Luxco SA, President of Astra Pain Control AB, Head of Biological Research at Pharmacia Ophthalmics AB, Regional Director at AstraZeneca Plc President of Astra Draco AB and Regional Director at Astra AB (both are subsidiaries of AstraZeneca Plc), Chairman for H. Lundbeck A, Chairman-Supervisory Board for Acino Pharma AG, Chairman of Acino Pharma AG, Chairman at Fougera Pharmaceuticals, Inc., Chief Executive Officer at Takeda A, Chief Executive Officer of Nyco Holdings 2 ApS, Chief Executive Officer at Nycomed Pharma Holding A, Chief Executive Officer at Takeda Pharmaceuticals International GmbH and President for Astra Paint (Pvt) Ltd.
Sven Håkan Björklund received a doctorate from Karolinska Institutet.